The Best-Seller Dance

By bmartin on May 4, 2010 8:45 AM |

By using newly released data from Thomson Reuters (for 2010 and 2014) and EvaluatePharma (for 2016), a timeline graphic of the 7 drugs that are expected to remain within the top 10 best sellers is presented. Notably only 1 of the 7, Crestor, is a conventional pill.

 

Best_sellers.pngAdvair (fluticasone/salmeterol; GSK) and Remicade (infliximab; Centocor Ortho Biotech) lose position, while the other drugs are expected to rise on the list. The future top seller, depending on your source, is Humira (adalimumab; Abbott) or Avastin (bevacizumab; Roche).

Categories:

Tags:

About this Entry

This page contains a single entry by bmartin published on May 4, 2010 8:45 AM.

Reasons for Unpublished Stroke Trials May Not Be Underhanded was the previous entry in this blog.

Here Comes the Sun, Maybe: High-Dose Vitamin D Possibly Beneficial in MS is the next entry in this blog.

Find recent content on the main index or look in the archives to find all content.

Powered by Movable Type 4.01